C1ORF124 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.00390000001838E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.07970000004809E-07 |
Normal-vs-Stage2 |
2.607200E-04 |
Normal-vs-Stage3 |
2.303800E-01 |
Normal-vs-Stage4 |
1.193380E-01 |
Stage1-vs-Stage2 |
8.800800E-01 |
Stage1-vs-Stage3 |
3.877500E-02 |
Stage1-vs-Stage4 |
9.251800E-01 |
Stage2-vs-Stage3 |
1.076780E-01 |
Stage2-vs-Stage4 |
8.628000E-01 |
Stage3-vs-Stage4 |
3.345800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.60029999995981E-06 |
Normal-vs-AfricanAmerican |
2.451399999992E-05 |
Normal-vs-Asian |
7.822300E-03 |
Caucasian-vs-AfricanAmerican |
7.856600E-01 |
Caucasian-vs-Asian |
7.877400E-01 |
AfricanAmerican-vs-Asian |
8.415200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.76789999493255E-08 |
Normal-vs-Female |
2.534300E-02 |
Male-vs-Female |
2.901800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.838600E-04 |
Normal-vs-Extreme_Weight |
2.19679999746702E-08 |
Normal-vs-Obese |
1.064000E-03 |
Normal-vs-Extreme_Obese |
3.363300E-04 |
Normal_Weight-vs-Extreme_Weight |
4.553800E-01 |
Normal_Weight-vs-Obese |
4.349800E-01 |
Normal_Weight-vs-Extreme_Obese |
6.343400E-01 |
Extreme_Weight-vs-Obese |
4.793700E-02 |
Extreme_Weight-vs-Extreme_Obese |
9.160800E-01 |
Obese-vs-Extreme_Obese |
2.924000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.284200E-02 |
Normal-vs-Age(41-60Yrs) |
7.838700E-04 |
Normal-vs-Age(61-80Yrs) |
1.15259999988737E-07 |
Normal-vs-Age(81-100Yrs) |
1.04299999970081E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.039200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.558820E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.042500E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.373500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.345720E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.108790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.66840000043389E-07 |
Normal-VS-Type2 PRCC |
1.151000E-04 |
Normal-VS-KIRP CIMP |
1.910000E-01 |
Normal-VS-Unclassified PRCC |
8.623800E-02 |
Type1 PRCC-VS-Type2 PRCC |
8.720000E-01 |
Type1 PRCC-VS-KIRP CIMP |
3.897400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
8.320200E-02 |
Type2 PRCC-VS-KIRP CIMP |
5.051600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.967050E-01 |
KIRP CIMP-VS-Unclassified PRCC |
8.868400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.65180000011311E-07 |
Normal-vs-N1 |
8.602400E-01 |
Normal-vs-N2 |
3.922500E-03 |
N0-vs-N1 |
1.256420E-02 |
N0-vs-N2 |
7.611000E-01 |
N1-vs-N2 |
2.133400E-01 |
|
|